iFyber

iFyber is a preclinical contract research organization (CRO) that provides specialized research and development services at the intersection of chemistry, biology, and materials science. The company serves industries including medical devices, wound care, diagnostics, and specialty textiles. Unlike traditional testing labs that perform commoditized assays, iFyber operates as an extension of client R&D teams by providing custom method development, experimental design, and consultative support. Its technical capabilities include microbial control, virology, analytical chemistry, and cell and tissue culture, all supported by a multidisciplinary team of scientists, many of whom hold advanced degrees. The firm leverages a high-touch, collaborative service model to solve complex challenges, ranging from exploratory conceptual evaluations to full-scale validation testing.

By integrating directly with client teams, iFyber helps accelerate development timelines, increase cost-effectiveness, and enhance competitive advantages for innovators. The company supports projects across various stages, from initial proof-of-concept to regulatory submission, ensuring that studies are aligned with intended clinical use and potential regulatory pathways. Their engagement is built on a fee-for-service model that preserves client intellectual property rights. Through state-of-the-art instrumentation and custom-designed experimental models, iFyber delivers reliable, actionable data that assists companies in navigating technical hurdles and advancing new technologies from the laboratory to the market.